TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12574761

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation home program (specific details on dosage and duration not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 10570332

Group type: EXPERIMENTAL
Intervention: Early endoscopy in the emergency department
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (endoscopy in 1 to 2 days)
Number of subjects: 110
Study: 8762852

Group type: EXPERIMENTAL
Intervention: Detection of IgG in cerebrospinal fluid (CSF)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Detection of anti-mycobacterial antibodies
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Detection of IgG or anti-mycobacterial antibodies or both
Number of subjects: 55

Group type: COMPARATOR
Intervention: Presence of IgG or anti-mycobacterial antibodies in other cases
Number of subjects: 55
Study: 1667955

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.9% saline solution (placebo)
Number of subjects: 20
Study: 6389653

Group type: EXPERIMENTAL
Intervention: Experimental group (relocated for nine weeks, managed by geriatrics team)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (remained in original units, managed by general medical surgical team)
Number of subjects: 36
Study: 31185773

Group type: EXPERIMENTAL
Intervention: Neck Group (NG) - observed neck images
Number of subjects: 48

Group type: COMPARATOR
Intervention: Foot Group (FG) - observed foot images
Number of subjects: 48
Study: 29246577

Group type: EXPERIMENTAL
Intervention: Prenatal repair of myelomeningocele
Number of subjects: 183

Group type: COMPARATOR
Intervention: Postnatal repair of myelomeningocele
Number of subjects: 183
Study: 27883159

Group type: EXPERIMENTAL
Intervention: Red wine and must
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Wines higher in melatonin and homovanillic acid
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Polyphenols in red wine matrix
Number of subjects: 18
Study: 25189113

Group type: EXPERIMENTAL
Intervention: Fusion surgery using a new flexible pedicle screw system (PLIF + 'topping off')
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional fusion surgery (PLIF)
Number of subjects: 0
Study: 22250993

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC), 3000 mg/day of elemental lanthanum
Number of subjects: 0
Study: 20861630

Group type: EXPERIMENTAL
Intervention: Visual inspection (ICDAS)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Laser fluorescence device (DIAGNOdent pen, LFpen)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Radiography
Number of subjects: 76
Study: 17397870

Group type: EXPERIMENTAL
Intervention: Home anticoagulation testing (HAT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Anticoagulation clinic service (ACS)
Number of subjects: 49
Study: 16222899

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg force-titrated to 80 mg after 1 month (n = 25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg force-titrated to 5 mg after 1 month (n = 25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg plus Ramipril 2.5 mg (n = 25)
Number of subjects: 75
Study: 12470127

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study: 9797077

Group type: EXPERIMENTAL
Intervention: ARMS-PCR
Number of subjects: 114

Group type: COMPARATOR
Intervention: Serology
Number of subjects: 114
Study: 7708866

Group type: EXPERIMENTAL
Intervention: Liposuction combined with full abdominoplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abdominoplasty alone
Number of subjects: 0
Study: 2676910

Group type: EXPERIMENTAL
Intervention: 5 mg/kg per day cyclosporin A (CsA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 799997

Group type: EXPERIMENTAL
Intervention: Cephradine (25-110 mg/kg per day) for 5-15 days
Number of subjects: 162

Group type: COMPARATOR
Intervention: Cephalexin (25-150 mg/kg per day) for 5-15 days
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Cephradine and Cephalexin
Number of subjects: 162
Study: 31615999

Group type: EXPERIMENTAL
Intervention: Analog computing system with coupled non-linear oscillators
Number of subjects: 0
Study: 28044988

Group type: EXPERIMENTAL
Intervention: Concomitant MitraClip (MC) and left atrial appendage occlusion (LAAO)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standalone MitraClip (MC)
Number of subjects: 25
Study: 25736975

Group type: EXPERIMENTAL
Intervention: 1700 mg metformin
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 23578448

Group type: EXPERIMENTAL
Intervention: Flail arm syndrome (FAS) patients
Number of subjects: 56
Study: 21690120

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Structured Brief Advice (SBA)
Number of subjects: 355
Study: 19794198

Group type: EXPERIMENTAL
Intervention: Optimised care model with training on diagnosis and treatment of anxiety disorders and psychiatric consultation-liaison service for 6 months
Number of subjects: 389

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 389
Study: 16798209

Group type: EXPERIMENTAL
Intervention: Blood cardioplegia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Crystalloid cardioplegia
Number of subjects: 30
Study: 12544454

Group type: EXPERIMENTAL
Intervention: 1.5 mg indapamide SR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 mg enalapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo run-in
Number of subjects: 0
Study: 10839487

Group type: EXPERIMENTAL
Intervention: Cefdinir 600 mg once daily (OD)
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Cefdinir 300 mg every 12 hours (BD)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 500/125 mg every 8 hours
Number of subjects: 569
Study: 8939177

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg, given four times daily for 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Albuterol 200 micrograms, given four times daily for 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 1492436

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 100

Group type: COMPARATOR
Intervention: AICD (control group)
Number of subjects: 100
Study: 3517473

Group type: EXPERIMENTAL
Intervention: Theophylline (Euphyllin retard)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31254639

Group type: EXPERIMENTAL
Intervention: Minocycline (100 mg twice daily)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 28657483

Group type: EXPERIMENTAL
Intervention: Student-initiated clinical encounter cards (CECs) for feedback
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard rotations (control group)
Number of subjects: 24
Study: 26886383

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Bag Mask Ventilation (BMV)
Number of subjects: 209
Study: 25226279

Group type: EXPERIMENTAL
Intervention: Traditional Asian Diet (TAD)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Typical Western Diet (TWD)
Number of subjects: 50
Study: 22052963

Group type: EXPERIMENTAL
Intervention: Walking intervention using Interactive Voice Response (IVR) system and mobile phones
Number of subjects: 71
Study: 20380847

Group type: EXPERIMENTAL
Intervention: PAM accelerometer with web-based tailored PA advice (PAM COACH)
Number of subjects: 87
Study: 17021584

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BT‐A) injection at gastrocnemius
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BT‐A) injection at adductors
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BT‐A) injection at gastrocnemius and adductors
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no injections)
Number of subjects: 60
Study: 16164922

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor (AI) formestane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no aromatase inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no antibodies)
Number of subjects: 0
Study: 12450691

Group type: EXPERIMENTAL
Intervention: ALM+BCG
Number of subjects: 75

Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Three injections of BCG
Number of subjects: 75
Study: 10225312

Group type: EXPERIMENTAL
Intervention: Triangular waveform pacing
Number of subjects: 32

Group type: COMPARATOR
Intervention: Square waveform pacing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intra-oesophageal lidocaine 20 mg/ml
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intra-oesophageal saline
Number of subjects: 32
Study: 7880743

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy
Number of subjects: 204

Group type: COMPARATOR
Intervention: Slightly hypofractionated regimen
Number of subjects: 204
Study: 2194128

Group type: EXPERIMENTAL
Intervention: Vitamin A (400,000 IU of retinyl palmitate, given orally; n = 92)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo (n = 97)
Number of subjects: 189
Study: 376307

Group type: EXPERIMENTAL
Intervention: Sodium valproate (VPA) at three different serum levels
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sodium valproate (VPA)
Number of subjects: 13
Study: 31361338

Group type: EXPERIMENTAL
Intervention: Real therapeutic ultrasound
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham therapeutic ultrasound
Number of subjects: 40
Study: 28329216

Group type: EXPERIMENTAL
Intervention: High altitude exposure (4350 m) on Day 0 (D0)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High altitude exposure (4350 m) on Day 2 (D2)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High altitude exposure (4350 m)
Number of subjects: 11
Study: 25937443

Group type: EXPERIMENTAL
Intervention: Desmoteplase (90 μg/kg) given 3-9 h after symptom onset
Number of subjects: 492

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Desmoteplase
Number of subjects: 492
Study: 23485996

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 196
Study: 21056069

Group type: EXPERIMENTAL
Intervention: Soluble fiber dextrin (12 g)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Soluble corn fiber (11.8 g)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Polydextrose (11.8 g)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resistant starch (11.2 g)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Isoenergetic low-fiber preload
Number of subjects: 36

Group type: COMPARATOR
Intervention: Lower-energy low-fiber preload
Number of subjects: 36
Study: 19277873

Group type: EXPERIMENTAL
Intervention: Stress management therapy (20 sessions of 2 hours each) and usual health care by a cardiologist
Number of subjects: 247

Group type: COMPARATOR
Intervention: Usual health care
Number of subjects: 247
Study: 16895887

Group type: EXPERIMENTAL
Intervention: PCC activity in activated PBLs
Number of subjects: 7

Group type: COMPARATOR
Intervention: PCC activity in control PBLs
Number of subjects: 7
Study: 15327428

Group type: EXPERIMENTAL
Intervention: r‐halphaGalA (1 mg/kg body weight continuously infused over 4 hours) during dialysis
Number of subjects: 10

Group type: COMPARATOR
Intervention: r‐halphaGalA (1 mg/kg body weight) administered separately in the interval between dialysis treatments
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High‐flux dialyzer
Number of subjects: 10
Study: 11466099

Group type: EXPERIMENTAL
Intervention: IL-6 (highest vs lowest quartile)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: CRP (highest vs lowest quartile)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: IL-6 (adjusted for confounders)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: CRP (adjusted for confounders)
Number of subjects: 550
Study: 9158882

Group type: EXPERIMENTAL
Intervention: Ormaplatin (30 min intravenous infusion)
Number of subjects: 28
Study: 7959280

Group type: EXPERIMENTAL
Intervention: Morphology index scores for malignant ovarian tumors (MI 7.3 +/- 1.9)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Assessment of interobserver variation in morphology index scoring
Number of subjects: 213
Study: 3669756

Group type: EXPERIMENTAL
Intervention: Recombinant alpha 2b-interferon injected subcutaneously 2 X 10(6) IU/m2, three times a week for 12 months.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Continued treatment with recombinant alpha 2b-interferon for 6 months after initial 12 months.
Number of subjects: 36

Group type: COMPARATOR
Intervention: No treatment after initial 12 months of interferon therapy.
Number of subjects: 36
Study: 31383718

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (30 minutes/session, 5 days/week)
Number of subjects: 400

Group type: COMPARATOR
Intervention: High aerobic exercise (60 minutes/session, 5 days/week)
Number of subjects: 400
Study: 28681267

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen (800 mg in 100 ml normal saline)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous paracetamol (1 g in 100 ml normal saline)
Number of subjects: 200
Study: 26699692

Group type: EXPERIMENTAL
Intervention: Constrained exercises (synergistic wrist and finger exercises with the metacarpophalangeal joint constrained)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Unconstrained exercises (traditional finger exercises with the metacarpophalangeal joint unconstrained)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Constrained exercises
Number of subjects: 66

Group type: COMPARATOR
Intervention: Unconstrained exercises
Number of subjects: 66
Study: 24080439

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA for 15 min)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cathodal tDCS (1 mA for 15 min)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham tDCS (1 mA for 15 min)
Number of subjects: 22
Study: 22371515

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation
Number of subjects: 31506
Study: 20569033

Group type: EXPERIMENTAL
Intervention: GSZ
Number of subjects: 26

Group type: COMPARATOR
Intervention: NZ
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: GSZ with neutralizing device
Number of subjects: 26
Study: 17652200

Group type: EXPERIMENTAL
Intervention: Fiber post placement
Number of subjects: 210

Group type: COMPARATOR
Intervention: No post placement (Control)
Number of subjects: 210
Study: 16081469

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (high-dose combination of calcium, magnesium, zinc, copper, selenium, vitamin A, thiamine, riboflavin, vitamin B6, folate, vitamin B12, vitamin C, vitamin E, vitamin D, Coenzyme Q10) for 9 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 9 months
Number of subjects: 30
Study: 11802135

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 548

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 548
Study: 10400846

Group type: COMPARATOR
Intervention: 60 mg of fexofenadine HCl twice daily
Number of subjects: 651

Group type: COMPARATOR
Intervention: 120 mg of sustained‐release pseudoephedrine HCl twice daily
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: 60 mg of fexofenadine HCl/120 mg of sustained‐release pseudoephedrine HCl twice daily
Number of subjects: 651
Study: 7477169

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus intensive chemotherapy and autologous bone marrow transplantation
Number of subjects: 215

Group type: COMPARATOR
Intervention: Chemotherapy without transplantation
Number of subjects: 215
Study: 2283674

Group type: EXPERIMENTAL
Intervention: Sphygmomat 2 blood pressure monitor
Number of subjects: 49

Group type: COMPARATOR
Intervention: Hawksley random zero sphygmomanometer
Number of subjects: 49
Study: 219470

Group type: EXPERIMENTAL
Intervention: procetofen (3 x 100 mg/day for 4-6 weeks)
Number of subjects: 6

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6
Study: 31560241

Group type: EXPERIMENTAL
Intervention: Check List for reporting product quality defects
Number of subjects: 338

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 338
Study: 30955220

Group type: EXPERIMENTAL
Intervention: 10-hydroxystearic acid (HSA)
Number of subjects: 0
Study: 27406859

Group type: EXPERIMENTAL
Intervention: Tomato products containing 30 mg lycopene per day
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Tomato products plus selenium, omega-3 fatty acids, soy isoflavones, grape/pomegranate juice, and green/black tea (tomato-plus)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Tomato products (lycopene)
Number of subjects: 79
Study: 25564179

Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of ketamine 1.0 mg/kg added to peritonsillar tramadol 2 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Peritonsillar saline and peritonsillar infiltration of tramadol 2 mg/kg
Number of subjects: 60
Study: 25528262

Group type: EXPERIMENTAL
Intervention: Exercise plus SCT-based behaviour change intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise plus education intervention
Number of subjects: 0
Study: 21181914

Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine (0-6 month schedule)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Dried blood spots (DBS)
Number of subjects: 74
Study: 19793040

Group type: EXPERIMENTAL
Intervention: Topical application (clindamycin, dexamethasone)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Systemic application (cefprozil, amoxicillin+clavulanate)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (no medications except analgesic)
Number of subjects: 78
Study: 17382220

Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg administered 30 minutes or more preoperatively and twice daily postoperatively until hospital discharge (7 or fewer postoperative days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg
Number of subjects: 0
Study: 15041504

Group type: EXPERIMENTAL
Intervention: Tramadol plus acetaminophen (APAP) 37.5 mg tramadol plus 325 mg APAP (n = 98)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Tramadol plus acetaminophen (APAP)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Codeine 30 mg plus APAP 300 mg (n = 109)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo (n = 98)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Codeine plus acetaminophen (APAP)
Number of subjects: 303
Study: 11483078

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 359

Group type: COMPARATOR
Intervention: Control eyes (non-treated)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: No ROP group
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Treated eyes (with cryotherapy)
Number of subjects: 359
Study: 9710723

Group type: EXPERIMENTAL
Intervention: Mepitel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Silver sulfadiazine
Number of subjects: 0
Study: 7905919

Group type: EXPERIMENTAL
Intervention: lorazepam (.05 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: diazepam (.25 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: midazolam (.1 mg/kg)
Number of subjects: 60
Study: 2567114

Group type: EXPERIMENTAL
Intervention: Dilevalol (200, 400, 800, 1,600 mg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Metoprolol (100, 200, 300, 400 mg)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Dilevalol (100, 200, 400, 800 mg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Atenolol (50, 100 mg)
Number of subjects: 2
Study: 5312322

Group type: EXPERIMENTAL
Intervention: Isoniazid (5 mg/kg body-weight daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoniazid (simultaneously with BCG vaccination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study: 31387081

Group type: EXPERIMENTAL
Intervention: Reduced preschool day (25% sitting)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Typical preschool day (50% sitting)
Number of subjects: 29
Study: 28467383

Group type: EXPERIMENTAL
Intervention: Total urinary polyphenol excretion (TPE) measured by the Folin‐Ciocalteu method
Number of subjects: 573
Study: 25244700

Group type: EXPERIMENTAL
Intervention: Drug-eluting balloons (DEB)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 310
Study: 23715820

Group type: EXPERIMENTAL
Intervention: Diet (DI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Exercise (EX)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise and Diet (EXD)
Number of subjects: 30
Study: 21324213

Group type: EXPERIMENTAL
Intervention: KAAA (Keto analogues and amino acids)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Lactose (Control group; LEx)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: KAAA (KEx)
Number of subjects: 13
Study: 18487854

Group type: EXPERIMENTAL
Intervention: Tourniquet release before wound closure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tourniquet release after wound closure
Number of subjects: 20
Study: 16563521

Group type: EXPERIMENTAL
Intervention: Olanzapine (5 to 20 mg/d)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Olanzapine-fluoxetine combination (6 and 25, 6 and 50, or 12 and 50 mg/d)
Number of subjects: 788

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 788
Study: 12878921

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 microg/kg twice daily for 8 weeks)
Number of subjects: 40
Study: 10719404

Group type: EXPERIMENTAL
Intervention: Pecan treatment group (68 g pecans per day for 8 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (avoided nuts)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Pecan treatment group
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 9013266

Group type: EXPERIMENTAL
Intervention: Nifedipine 60 mg
Number of subjects: 129

Group type: COMPARATOR
Intervention: Atenolol 100 mg
Number of subjects: 129
Study: 1358119

Group type: EXPERIMENTAL
Intervention: (-)-3PPP (preclamol) administered intramuscularly at doses of 30-40 mg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4